C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

“Guo Chao” Packaging Design Week makes its surprise debut at swop 2021

Wednesday, June 16, 2021

In recent years Guo Chao has been rising Concepts such as madeinChina crossover cobranding and IP have become hot topics in todays society The rise of Guo Chao has also brought vitality and new opportunities for the packaging industry The Baidu Guo C...

Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206

Wednesday, June 30, 2021

Spero Therapeutics Inc a multiasset clinicalstage biopharmaceutical company focused on identifying developing and commercializing treatments in high unmet need areas involving multidrug resistant bacterial infections and rare diseases today announc...

Allogene Therapeutics Granted FDA Fast Track Designation for ALLO-605, the First TurboCAR™ T Cell Therapy, for the Treatment of Relapsed/Refractory Multiple Myeloma

Wednesday, June 30, 2021

Allogene Therapeutics Inc a clinicalstage biotechnology company pioneering the development of allogeneic CAR T AlloCAR T therapies for cancer today announced that the US Food and Drug Administration FDA has granted Fast Track designation to ALLO the...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Wednesday, June 30, 2021

Jazz Pharmaceuticals plc today announced the US Food and Drug Administration FDA approval of Rylaze asparaginase erwinia chrysanthemi recombinantrywn for use as a component of a multiagent chemotherapeutic regimen for the treatment of acute lymphobla...

PHARMAP 2021: Navigation Map Through The Pharma Trends

Wednesday, June 30, 2021

Connecting the whole pharmaceutical value chain and focusing on manufacturing and packaging sides of the industry were the main directions of the Pharmaceutical Manufacturing and Packaging Congress PHARMAP It took place on the BGS online platform o...

Rentschler Biopharma expands production of highly complex antibodies at German site

Wednesday, June 30, 2021

Antibody therapies have become an integral part of treating serious and rare diseases It is all the more important that we have a high level of expertise in drug development as well as in bioprocess development and production of therapeutic antibodie...

Lonza Invests CHF 20 million to Expand API Development and Manufacturing Facility in Nansha, China

Tuesday, June 29, 2021

Lonza today announced new investments in GMP laboratories and midscale manufacturing assets at its API manufacturing center in Nansha China The investments totaling over CHF million will allow Lonza to provide a smoother transition from smallscale t...

Roche’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)

Monday, June 28, 2021

Roche announced today that the European Commission EC has approved ENSPRYNG satralizumab for the treatment of adults and adolescents from years of age living with antiaquaporin antibody AQPIgG seropositive neuromyelitis optica spectrum disorder NMOS...

Innovent Announces License Agreement with Synaffix in an ADC Technology Deal

Monday, June 28, 2021

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of cancer metabolic autoimmune and other major diseases announced the signing of a nonexclusive target...

AskBio Receives FDA Fast Track Designation for LION-101, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)

Monday, June 28, 2021

Asklepios BioPharmaceutical Inc AskBio a wholly owned and independently operated subsidiary of Bayer AG announced that the US Food Drug Administration FDA has granted Fast Track Designation for the LION gene therapy program LION is a novel recombina...